Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU

Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T – an intrapatient comparison

Andreas Rinscheid, Alexander Dierks, Malte Kircher, Christian Pfob, Hermann Wengenmair, Georgine Wienand, Constantin Lapa, Tilman Janzen and Ralph Bundschuh
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P346;

Article Information

vol. 64 no. supplement 1 P346
Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 28, 2023.
Copyright & Usage 
© 2023

Author Information

  1. Andreas Rinscheid1,
  2. Alexander Dierks2,
  3. Malte Kircher3,
  4. Christian Pfob4,
  5. Hermann Wengenmair5,
  6. Georgine Wienand6,
  7. Constantin Lapa2,
  8. Tilman Janzen5 and
  9. Ralph Bundschuh7
  1. 1Medical Physics and Radiation Protection, University Hospital Augsburg
  2. 2University of Augsburg
  3. 3Nuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.
  4. 4University of Augsburg, Faculty of Medicine, Nuclear Medicine
  5. 5University Hospital Augsburg
  6. 6Nuclear Medicine, Medical Faculty, University of Augsburg
  7. 7Nuclear Medicine, Faculty of Medicine, University Hospital Augsburg, Augsburg, Germany

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: August 2023 to April 2025

AbstractFullPdf
Aug 2023100
Sep 20234400
Oct 20233200
Nov 20233500
Dec 20232900
Jan 20243100
Feb 20241200
Mar 20242300
Apr 20245200
May 20241600
Jun 20244700
Jul 202411500
Aug 20248000
Sep 2024900
Oct 20242000
Nov 20241900
Dec 2024800
Jan 20251200
Feb 20251000
Mar 2025700
Apr 20251300
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
Article Alerts
Email Article
Citation Tools
Bookmark this article

Jump to section